DOI: 10.21276/ajptr
Thu, 23 May 2019

Avanafil: A Novel Agent for Management of Erectile Dysfunction, Its Clinical And Analytical Approach

Jasmin Kubawat, YK. Agrawal, Unnati S. Patel*

1. Institute of Research and Development, Gujarat Forensic Sciences University, Gandhinagar-382007, Gujarat, India.


Erectile dysfunction is the sexual dysfunction characterized by inability to maintain an erection of penis during sexual performance. Oral phosphodiesterase type 5 inhibitors drugs are successful for treatment of impotence such as sildenafil, vardenafil, tadalafil, alprostadil and avanafil. Clinical trials reveals that avanafil have faster onset of action as well as higher specificity for phosphodiesterase type 5 inhibitors with fewer side effects in comparision of other oral phosphodiesterase type 5 inhibitors drugs. In case of analytical method only LC-MS/MS method has been done. There may be chances of analytical study of avanafil will be done in future by using various spectroscopy method.

Keywords: Avanafil, Erectile dysfunction, Clinical Study, Analytical Approach

[PDF]   Viewed: 1533   Downloaded: 171
  • Call for paper

    American Journal of PharmTech Research (AJPTR) is a peer-reviewed, bimonthly official international journal allowing access to abstracts and full-text.



  • Email & SMS Alerts

    Email/SMS alert system is one of the key features and gives update information about the submitted manuscript.


  • Article Statastics

    American Journal of PharmTech Research (AJPTR) provides unique facility for authors to know popularity of articles on basis of numbers of PDF download and views. It will display in tabulated format.

  • Online Submission

    American Journal of PharmTech Research (AJPTR) is one of the International open access journal devoted to various disciplines in science and technology.


web counter
web counter